BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 92.10
+4.79 (5.49%)
At close: Jul 22, 2025, 2:57 PM CST
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 40.02 billion as of July 23, 2025. Its market cap has increased by 161.21% in one year.
Market Cap
40.02B
Enterprise Value
41.56B
Revenue
1.19B
Ranking
n/a
PE Ratio
289.34
Stock Price
92.10
Market Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 40.02B, an increase of 218.90%. That is a compound annual growth rate of 22.52%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 391.84B |
| Shenzhen Mindray Bio-Medical Electronics | 272.50B |
| WuXi AppTec | 236.12B |
| Sichuan Biokin Pharmaceutical | 128.74B |
| Zhangzhou Pientzehuang Pharmaceutical., | 120.04B |
| Aier Eye Hospital Group | 116.29B |
| Shanghai United Imaging Healthcare | 104.88B |
| Yunnan Baiyao Group Co.,Ltd | 100.33B |